Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

The histamine-inhalational test 

The histamine-inhalational test
Chapter:
The histamine-inhalational test
Author(s):

Bruce R Thompson

and Robyn E O’Hehir

DOI:
10.1093/med/9780199651559.003.0045
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 March 2021

It is well known that asthmatics demonstrate an increased reactivity of the bronchial airways to chemical mediators like histamine. . . . Inhalation tests with histamine were introduced by Curry in 1946 and since then have been widely used to study non-specific bronchial reactivity. However, the methods have not been standardized and the results are difficult to interpret. In this paper we use a simple dose-response method to examine the effects of inhaled histamine in normal subjects, well controlled asthmatics, and patients with rhinitis or chronic cough. Histamine-inhalation tests were carried out in 307 adults. . . . Non-specific bronchial reactivity was increased in 3% of presumed normal subjects, in 100% of active asthmatics and in 69% of asymptomatic asthmatics with previous symptoms only at times of exposure to clinically relevant allergens. It was also increased in 47% of patients with cough and no other chest symptoms, in 40% of patients with rhinitis and vague chest symptoms not by themselves diagnostic of asthma, and in 22% of patients with rhinitis and no chest symptoms. . . . The results draw attention to the clinical relevance of increased bronchial reactivity and particularly to the close relationship between the level of increased reactivity and minimum therapy required to maintain good control of asthma.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.